The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
The scheme aims to avoid disruption in supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs
Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
The company has now received 100% of the incentive owed to the company for the financial year 2022-23 under the PLI scheme
The approval has been accorded by IFCI Limited for manufacturing of the product "7 ACA"
The minister exhorted the pharmaceutical sector to prepare a plan for the next 25 years
The company inaugurated the new production line at the Bengaluru facility to manufacture Computed Tomography Scanners
It is one of the 15 medical device manufacturers approved under the government’s PLI scheme
A total of 21 applicants have been approved for 49 products, with the potential to utilize an incentive amount of Rs. 2541 crore
The bulk drug plants that have already been commissioned include CDA, para amino phenol, atorvastatin, sulfadiazine, oxcarbazepine, levofloxacin, carbidopa and levodopa
Subscribe To Our Newsletter & Stay Updated
